FDA Import Refusal AEK-5258120-2/11/1 — SYMBIOSIS PHARMACEUTICALS PVT
The FDA refused shipment AEK-5258120-2/11/1 from SYMBIOSIS PHARMACEUTICALS PVT (India) on May 31, 2024. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- May 31, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75